<\/span><\/h3>\nRecent advances include personalised CAR T-cell therapies, neoantigen-based vaccines, bispecific antibodies, and expanded use of checkpoint inhibitors. These developments are bringing immunotherapy into the treatment of more cancer types, including those previously hard to manage.<\/p>\n
<\/span>6. Why is cancer so difficult to cure?<\/span><\/h3>\nCancer is difficult to cure because it is not one disease but a collection of many, each with its own genetic and biological variations (heterogeneous diseases). Tumours also adapt quickly, which makes treatment more challenging.<\/p>\n
<\/span>7. Which cancers are most successfully treated with immunotherapy?<\/span><\/h3>\nImmunotherapy has shown the most success in cancers such as melanoma, lung cancer, breast cancer, kidney cancer, and certain blood cancers like lymphoma and leukaemia (both acute and chronic). Doctors determine suitability based on tumour characteristics and patient factors.<\/p>\n
<\/span>8. What is the danger of immunotherapy?<\/span><\/h3>\nImmunotherapy can overstimulate the immune system, leading to side effects such as inflammation in healthy tissues and organs. These can range from mild to severe, and treatment should always be closely monitored by specialists.<\/p>\n
<\/span>9. Which cancers do not respond to immunotherapy?<\/span><\/h3>\nSome cancers, including pancreatic cancer and certain types of brain tumours, often do not respond well to immunotherapy. Research is ongoing to understand why and to develop strategies to improve responses.<\/p>\n
\nMedically Reviewed by<\/strong>\u200a\u2014\u200aDr. Sunil Kumar Gupta (Principal Director & HOD \u2013 Haemato Medical Oncology & Bone Marrow Transplant)\n<\/p>\n<\/blockquote>\n